Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F MacDonald

Showing results (461-470 of 486) with videos related to

Pageof 49
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2009
Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptorKeith Biggadike, Randy K Bledsoe, Diane M Coe, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 28, 2001
Mutation analysis of the MECP2 gene in British and Italian Rett syndrome femalesM Vacca, F Filippini, A Budillon, et al.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicityHawa Diallo, Davina C Angell, Heather A Barnett, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2008
Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonistsHeather A Barnett, Diane M Coe, Tony W J Cooper, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|January 6, 2012
A spectrometer designed for 6.7 and 14.1 T DNP-enhanced solid-state MAS NMR using quasi-optical microwave transmissionKevin J Pike, Thomas F Kemp, Hiroki Takahashi, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
Brain & Development|December 12, 2001
MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved regionM Vacca, F Filippini, A Budillon, et al.
Journal of Medicinal Chemistry|November 28, 2007
Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivityKeith Biggadike, Mohamed Boudjelal, Margaret Clackers, et al.
Pageof 49

Showing results (461-470 of 486) with videos related to

Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2009
Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptorKeith Biggadike, Randy K Bledsoe, Diane M Coe, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 28, 2001
Mutation analysis of the MECP2 gene in British and Italian Rett syndrome femalesM Vacca, F Filippini, A Budillon, et al.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicityHawa Diallo, Davina C Angell, Heather A Barnett, et al.
Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α<sub>v</sub>β<sub>6</sub> Integrin Inhibitor-(3<i>S</i>)-3-(3-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)phenyl)-4-((1<i>S</i> and 1<i>R</i>,3<i>R</i>)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2008
Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonistsHeather A Barnett, Diane M Coe, Tony W J Cooper, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|January 6, 2012
A spectrometer designed for 6.7 and 14.1 T DNP-enhanced solid-state MAS NMR using quasi-optical microwave transmissionKevin J Pike, Thomas F Kemp, Hiroki Takahashi, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
Brain & Development|December 12, 2001
MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved regionM Vacca, F Filippini, A Budillon, et al.
Journal of Medicinal Chemistry|November 28, 2007
Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivityKeith Biggadike, Mohamed Boudjelal, Margaret Clackers, et al.
Pageof 49